Search Count: 5
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: 4HW |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Diseases
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: 4HZ |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Diseases
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: 467 |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.52 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: VJK |
 |
3-Aryl-4-(Arylhydrazono)-1H-Pyrazol-5-Ones: Highly Ligand Efficient And Potent Inhibitors Of Gsk3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2010-03-02 Classification: TRANSFERASE Ligands: Z92, PO4 |